Cambridge Biotech Firm Secures $60M for RNA Editing Therapies - Funding Raised

Cambridge Biotech Firm Secures $60M for RNA Editing Therapies

Cambridge-based biotech company AIRNA has closed a $60 million financing round, bringing its total Series A funding to $90 million. Led by Forbion with new and existing investors, the funds will advance AIRNA’s lead RNA editing therapeutic into clinical trials and further develop its pipeline.

Latest News

Read More

Mafix

August 24, 2026

Mafix Funding Silicon Fertilizer Startup ने जुटाए $5.4 मिलियन,

Stanford spinout Mafix ने $5.4 मिलियन Pre-Seed funding जुटाई है। कंपनी silicon fertilizer बनाकर soil health सुधारने और

By Vaishali Sharma

Symbiotec Pharmalab

August 24, 2026

🚀 Symbiotec Pharmalab IPO 2026 GMP, Subscription, Allotment Date और Apply करें या नहीं? पूरी जानकारी

Symbiotec Pharmalab IPO 2026 आज खुल गया है। जानें GMP, Price Band, Subscription, Allotment Date, Listing Date और

By Vaishali Sharma

Sterling Accuris

August 24, 2026

Sterling Accuris FY26 Results Revenue ₹231 करोड़ पहुंचा, लेकिन Loss 38% बढ़ा

Morgan Stanley-backed Sterling Accuris ने FY26 में ₹231 करोड़ revenue दर्ज किया। कंपनी का net loss 38% बढ़ा,

By Vaishali Sharma